- Home
- AOS vs NBIX Comparison
AOS vs NBIX Comparison
Compare AOS & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AOS
- NBIX
- Stock Information
- Founded
- AOS 1874
- NBIX 1992
- Country
- AOS United States
- NBIX United States
- Employees
- AOS N/A
- NBIX N/A
- Industry
- AOS Industrial Machinery/Components
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AOS Industrials
- NBIX Health Care
- Exchange
- AOS Nasdaq
- NBIX Nasdaq
- Market Cap
- AOS 9.8B
- NBIX 11.0B
- IPO Year
- AOS N/A
- NBIX 1996
- Fundamental
- Price
- AOS $63.14
- NBIX $101.38
- Analyst Decision
- AOS Buy
- NBIX Strong Buy
- Analyst Count
- AOS 6
- NBIX 21
- Target Price
- AOS $76.50
- NBIX $163.00
- AVG Volume (30 Days)
- AOS 1.7M
- NBIX 1.8M
- Earning Date
- AOS 04-29-2025
- NBIX 05-05-2025
- Dividend Yield
- AOS 2.16%
- NBIX N/A
- EPS Growth
- AOS N/A
- NBIX 33.20
- EPS
- AOS 3.63
- NBIX 3.29
- Revenue
- AOS $3,818,100,000.00
- NBIX $2,355,300,000.00
- Revenue This Year
- AOS $1.52
- NBIX $15.48
- Revenue Next Year
- AOS $4.90
- NBIX $15.99
- P/E Ratio
- AOS $17.39
- NBIX $30.81
- Revenue Growth
- AOS N/A
- NBIX 24.81
- 52 Week Low
- AOS $58.83
- NBIX $84.23
- 52 Week High
- AOS $92.45
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- AOS 44.08
- NBIX 46.65
- Support Level
- AOS $62.44
- NBIX $84.23
- Resistance Level
- AOS $65.59
- NBIX $112.74
- Average True Range (ATR)
- AOS 1.97
- NBIX 5.17
- MACD
- AOS 0.05
- NBIX 0.59
- Stochastic Oscillator
- AOS 58.09
- NBIX 60.45
About AOS A.O. Smith Corporation
A.O. Smith manufactures a broad lineup of water heaters, boilers, and water treatment products. The company has two reporting segments: North America (75% of sales) and rest of world (25% of sales). A.O. Smith is the leading manufacturer of water heaters in North America for the residential and commercial markets, with approximately 37% and 54% market share, respectively. Residential water heaters account for Most of North American sales and are distributed equally through wholesale and retail channels. Most of A.O. Smith's international revenue is from China, a market the company entered during the mid-1990s.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.